<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8167.22744 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/24/2022 5:57:53 PM-->
<!--Modified on: 8/24/2022 5:57:53 PM-->
<xsd:schema targetNamespace="http://www.bio-techne.com/20220630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:attributeFormDefault="unqualified" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tech="http://www.bio-techne.com/20220630">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/StatementConsolidatedStatementsOfEarningsAndComprehensiveIncome" id="StatementConsolidatedStatementsOfEarningsAndComprehensiveIncome">
        <link:definition>00100 - Statement - Consolidated Statements of Earnings and Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>00200 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>00400 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationInventoriesDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationInventoriesDetails">
        <link:definition>40302 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationPropertyAndEquipmentDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationPropertyAndEquipmentDetails">
        <link:definition>40303 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationIntangibleAssetsDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationIntangibleAssetsDetails">
        <link:definition>40304 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationEstimatedFutureAmortizationExpenseForIntangibleAssetsDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationEstimatedFutureAmortizationExpenseForIntangibleAssetsDetails">
        <link:definition>40306 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Estimated Future Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureAcquisitionsPreliminaryAndFinalFairValueOfAssetsAndLiabilitiesAssumedDetails" id="DisclosureAcquisitionsPreliminaryAndFinalFairValueOfAssetsAndLiabilitiesAssumedDetails">
        <link:definition>40402 - Disclosure - Acquisitions - Preliminary and Final Fair Value of Assets and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" id="DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
        <link:definition>40502 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureLeasesBalanceSheetClassificationDetails" id="DisclosureLeasesBalanceSheetClassificationDetails">
        <link:definition>40702 - Disclosure - Leases - Balance Sheet Classification (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureLeasesFairValueOfLeaseLiabilityByPaymentDateDetails" id="DisclosureLeasesFairValueOfLeaseLiabilityByPaymentDateDetails">
        <link:definition>40704 - Disclosure - Leases - Fair Value of the Lease Liability by Payment Date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureEarningsPerShareSharesUsedInEarningsPerShareComputationsDetails" id="DisclosureEarningsPerShareSharesUsedInEarningsPerShareComputationsDetails">
        <link:definition>40902 - Disclosure - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureIncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" id="DisclosureIncomeTaxesComponentsOfProvisionForIncomeTaxesDetails">
        <link:definition>41102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureIncomeTaxesReconciliationOfFederalTaxCalculatedAtStatutoryRateDetails" id="DisclosureIncomeTaxesReconciliationOfFederalTaxCalculatedAtStatutoryRateDetails">
        <link:definition>41103 - Disclosure - Income Taxes - Reconciliation of Federal Tax Calculated at Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureIncomeTaxesTemporaryDifferencesComprisingDeferredTaxesOnConsolidatedBalanceSheetsDetails" id="DisclosureIncomeTaxesTemporaryDifferencesComprisingDeferredTaxesOnConsolidatedBalanceSheetsDetails">
        <link:definition>41104 - Disclosure - Income Taxes - Temporary Differences Comprising Deferred Taxes on Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/StatementConsolidatedBalanceSheetsParentheticals" id="StatementConsolidatedBalanceSheetsParentheticals">
        <link:definition>00205 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/StatementConsolidatedStatementsOfShareholdersEquity" id="StatementConsolidatedStatementsOfShareholdersEquity">
        <link:definition>00300 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" id="DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies">
        <link:definition>10101 - Disclosure - Description of Business and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureRevenueRecognition" id="DisclosureRevenueRecognition">
        <link:definition>10201 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformation" id="DisclosureSupplementalBalanceSheetAndCashFlowInformation">
        <link:definition>10301 - Disclosure - Supplemental Balance Sheet and Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureAcquisitions" id="DisclosureAcquisitions">
        <link:definition>10401 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>10501 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureDebtAndOtherFinancingArrangements" id="DisclosureDebtAndOtherFinancingArrangements">
        <link:definition>10601 - Disclosure - Debt and Other Financing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureLeases" id="DisclosureLeases">
        <link:definition>10701 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformation" id="DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformation">
        <link:definition>10801 - Disclosure - Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureEarningsPerShare" id="DisclosureEarningsPerShare">
        <link:definition>10901 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureShareBasedCompensationAndOtherBenefitPlans" id="DisclosureShareBasedCompensationAndOtherBenefitPlans">
        <link:definition>11001 - Disclosure - Share-based Compensation and Other Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>11101 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSegmentInformation" id="DisclosureSegmentInformation">
        <link:definition>11201 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>11301 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>20102 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" id="DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>30103 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureRevenueRecognitionTables" id="DisclosureRevenueRecognitionTables">
        <link:definition>30203 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationTables" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationTables">
        <link:definition>30303 - Disclosure - Supplemental Balance Sheet and Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureAcquisitionsTables" id="DisclosureAcquisitionsTables">
        <link:definition>30403 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>30503 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>30703 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformationTables" id="DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformationTables">
        <link:definition>30803 - Disclosure - Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureEarningsPerShareTables" id="DisclosureEarningsPerShareTables">
        <link:definition>30903 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSegmentInformationTables" id="DisclosureSegmentInformationTables">
        <link:definition>31203 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" id="DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>40101 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>40102 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesRestructuringChargesDetails" id="DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesRestructuringChargesDetails">
        <link:definition>40103 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureRevenueRecognitionNarrativeDetails" id="DisclosureRevenueRecognitionNarrativeDetails">
        <link:definition>40201 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureRevenueRecognitionDisaggregationOfRevenueDetails" id="DisclosureRevenueRecognitionDisaggregationOfRevenueDetails">
        <link:definition>40202 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationNarrativeDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationNarrativeDetails">
        <link:definition>40301 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationChangesToCarryingAmountOfNetIntangibleAssetsDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationChangesToCarryingAmountOfNetIntangibleAssetsDetails">
        <link:definition>40305 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Changes to Carrying Amount of Net Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationChangesInCarryingAmountOfGoodwillDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationChangesInCarryingAmountOfGoodwillDetails">
        <link:definition>40307 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureSupplementalBalanceSheetAndCashFlowInformationSupplementalCashFlowInformationDetails" id="DisclosureSupplementalBalanceSheetAndCashFlowInformationSupplementalCashFlowInformationDetails">
        <link:definition>40308 - Disclosure - Supplemental Balance Sheet and Cash Flow Information - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureAcquisitionsNarrativeDetails" id="DisclosureAcquisitionsNarrativeDetails">
        <link:definition>40401 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureFairValueMeasurementsNarrativeDetails" id="DisclosureFairValueMeasurementsNarrativeDetails">
        <link:definition>40501 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureFairValueMeasurementsLiabilityMeasuredAtFairValueOnRecurringBasisUsingSignificantUnobservableInputsDetails" id="DisclosureFairValueMeasurementsLiabilityMeasuredAtFairValueOnRecurringBasisUsingSignificantUnobservableInputsDetails">
        <link:definition>40503 - Disclosure - Fair Value Measurements - Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureDebtAndOtherFinancingArrangementsNarrativeDetails" id="DisclosureDebtAndOtherFinancingArrangementsNarrativeDetails">
        <link:definition>40601 - Disclosure - Debt and Other Financing Arrangements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureLeasesNarrativeDetails" id="DisclosureLeasesNarrativeDetails">
        <link:definition>40701 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureLeasesCashPaidDetails" id="DisclosureLeasesCashPaidDetails">
        <link:definition>40703 - Disclosure - Leases - Cash Paid (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformationNarrativeDetails" id="DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformationNarrativeDetails">
        <link:definition>40801 - Disclosure - Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformationChangesInAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" id="DisclosureSupplementalEquityAndAccumulatedOtherComprehensiveIncomeLossInformationChangesInAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails">
        <link:definition>40802 - Disclosure - Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureEarningsPerShareNarrativeDetails" id="DisclosureEarningsPerShareNarrativeDetails">
        <link:definition>40901 - Disclosure - Earnings Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureShareBasedCompensationAndOtherBenefitPlansDetails" id="DisclosureShareBasedCompensationAndOtherBenefitPlansDetails">
        <link:definition>41001 - Disclosure - Share-based Compensation and Other Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureShareBasedCompensationAndOtherBenefitPlansAssumptionsUsedInBlackScholesOptionPricingModelDetails" id="DisclosureShareBasedCompensationAndOtherBenefitPlansAssumptionsUsedInBlackScholesOptionPricingModelDetails">
        <link:definition>41002 - Disclosure - Share-based Compensation and Other Benefit Plans - Assumptions Used in Black-Scholes Option-Pricing Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureShareBasedCompensationAndOtherBenefitPlansStockOptionActivityDetails" id="DisclosureShareBasedCompensationAndOtherBenefitPlansStockOptionActivityDetails">
        <link:definition>41003 - Disclosure - Share-based Compensation and Other Benefit Plans - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureShareBasedCompensationAndOtherBenefitPlansRestrictedStockAndRestrictedStockUnitsActivityDetails" id="DisclosureShareBasedCompensationAndOtherBenefitPlansRestrictedStockAndRestrictedStockUnitsActivityDetails">
        <link:definition>41004 - Disclosure - Share-based Compensation and Other Benefit Plans - Restricted Stock and Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureIncomeTaxesNarrativeDetails" id="DisclosureIncomeTaxesNarrativeDetails">
        <link:definition>41101 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails">
        <link:definition>41105 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureSegmentInformationNarrativeDetails" id="DisclosureSegmentInformationNarrativeDetails">
        <link:definition>41201 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/20211231/role/DisclosureSegmentInformationFinancialInformationRelatingToReportableSegmentsDetails" id="DisclosureSegmentInformationFinancialInformationRelatingToReportableSegmentsDetails">
        <link:definition>41202 - Disclosure - Segment Information - Financial Information Relating to Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>41301 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureShareBasedCompensationAndOtherBenefitPlansTables" id="DisclosureShareBasedCompensationAndOtherBenefitPlansTables">
        <link:definition>31003 - Disclosure - Share-based Compensation and Other Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>31103 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tmb-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.bio-techne.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xsd:element name="APACExcludingGreaterChinaMember" id="tech_APACExcludingGreaterChinaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccountsReceivableOfImpairedAssetGroup" id="tech_AccountsReceivableOfImpairedAssetGroup" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AcquisitionOfAsuragenIncMember" id="tech_AcquisitionOfAsuragenIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AmortizationOfAcquiredIntangibleAssets" id="tech_AmortizationOfAcquiredIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="AssetImpairmentMember" id="tech_AssetImpairmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AssetImpairmentRestructuringCharge" id="tech_AssetImpairmentRestructuringCharge" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" id="tech_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentAndOtherLongtermAssets" id="tech_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentAndOtherLongtermAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesExcludingDeferredIncomeTaxesTotal" id="tech_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesExcludingDeferredIncomeTaxesTotal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CCXIMember" id="tech_CCXIMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConsumablesMember" id="tech_ConsumablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContingentConsiderationMember" id="tech_ContingentConsiderationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CreditAgreementMember" id="tech_CreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CurrentLiabilitiesOfImpairedAssetGroup" id="tech_CurrentLiabilitiesOfImpairedAssetGroup" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DerivativeNotionalAmountDecreaseInPeriod" id="tech_DerivativeNotionalAmountDecreaseInPeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DerivativeNotionalAmountDedesignated" id="tech_DerivativeNotionalAmountDedesignated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DiagnosticsAndGenomicsMember" id="tech_DiagnosticsAndGenomicsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EMEAExcludingUKMember" id="tech_EMEAExcludingUKMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeeSeveranceOnRelocationOfUSPlantMember" id="tech_EmployeeSeveranceOnRelocationOfUSPlantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeeStockPurchasePlan2014Member" id="tech_EmployeeStockPurchasePlan2014Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FairValueAdjustmentOnAvailableForSaleSecurities" id="tech_FairValueAdjustmentOnAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueAdjustmentToContingentConsiderationPayable" id="tech_FairValueAdjustmentToContingentConsiderationPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueWriteUpOfAcquiredInventory" id="tech_FairValueWriteUpOfAcquiredInventory" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FinitelivedIntangibleAssetsOtherAdditions" id="tech_FinitelivedIntangibleAssetsOtherAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FirstPartOfForwardContractMember" id="tech_FirstPartOfForwardContractMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FixedAssetsAndRelatedDepositsMember" id="tech_FixedAssetsAndRelatedDepositsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ForwardContractAdditionalInvestment" id="tech_ForwardContractAdditionalInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="ForwardContractMilestoneAnnualEBITDA" id="tech_ForwardContractMilestoneAnnualEBITDA" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ForwardContractMilestoneAnnualRevenueRequired" id="tech_ForwardContractMilestoneAnnualRevenueRequired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ForwardContractMilestoneMultipleForTotalExpectedPayments" id="tech_ForwardContractMilestoneMultipleForTotalExpectedPayments" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ForwardStartingSwapMember" id="tech_ForwardStartingSwapMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncomeLossFromNoncontrollingInterestAttributableToParent" id="tech_IncomeLossFromNoncontrollingInterestAttributableToParent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncomeTaxExpenseBenefitDiscreteTaxItems" id="tech_IncomeTaxExpenseBenefitDiscreteTaxItems" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="InstrumentsMember" id="tech_InstrumentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="InventoryFinishedGoodsNetOfReservesNonCurrent" id="tech_InventoryFinishedGoodsNetOfReservesNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="InventoryNetCurrentAndNonCurrent" id="tech_InventoryNetCurrentAndNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="InventoryOfImpairedAssetGroup" id="tech_InventoryOfImpairedAssetGroup" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="InvestmentInUnconsolidatedEntity" id="tech_InvestmentInUnconsolidatedEntity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="LesseeOperatingLeaseAssetAndLiabilitiesTableTextBlock" id="tech_LesseeOperatingLeaseAssetAndLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LesseeOperatingLeaseCashFlowInformationTableTextBlock" id="tech_LesseeOperatingLeaseCashFlowInformationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LineOfCreditFacilityAdditionalBorrowingCapacity" id="tech_LineOfCreditFacilityAdditionalBorrowingCapacity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="NewForwardStartingSwapMember" id="tech_NewForwardStartingSwapMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NoncashPortionOfLeaseExpense" id="tech_NoncashPortionOfLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="OtherCurrentAssetsOfImpairedAssetGroup" id="tech_OtherCurrentAssetsOfImpairedAssetGroup" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="PercentageOfInterestInTangibleAssetsInLiquidationProcess" id="tech_PercentageOfInterestInTangibleAssetsInLiquidationProcess" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ProceedsFromLaboratoryServicesReimbursedByMedicare" id="tech_ProceedsFromLaboratoryServicesReimbursedByMedicare" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ProductAndServicesMember" id="tech_ProductAndServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PropertyPlantAndEquipmentOfImpairedAssetGroup" id="tech_PropertyPlantAndEquipmentOfImpairedAssetGroup" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="ProteinSciencesMember" id="tech_ProteinSciencesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="QTHoldingsCorporationMember" id="tech_QTHoldingsCorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestOfWorldMember" id="tech_RestOfWorldMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestructuringActionsPolicyTextBlock" id="tech_RestructuringActionsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SecondPartOfForwardContractMember" id="tech_SecondPartOfForwardContractMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TermLoanMember" id="tech_TermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="UndesignatedCapitalStockNoParValue" id="tech_UndesignatedCapitalStockNoParValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="UndesignatedCapitalStockSharesAuthorized" id="tech_UndesignatedCapitalStockSharesAuthorized" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="UndesignatedCapitalStockSharesIssued" id="tech_UndesignatedCapitalStockSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="UndesignatedCapitalStockSharesOutstanding" id="tech_UndesignatedCapitalStockSharesOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="UndesignatedCapitalStockValue" id="tech_UndesignatedCapitalStockValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="WilsonWolfCorporationMember" id="tech_WilsonWolfCorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SurrenderAndRetirementOfStockToExerciseOptionsShares" id="tech_SurrenderAndRetirementOfStockToExerciseOptionsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SurrenderAndRetirementOfStockToExerciseOptionsValue" id="tech_SurrenderAndRetirementOfStockToExerciseOptionsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="GainLossOnEscrowSettlement" id="tech_GainLossOnEscrowSettlement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="TradeNamesCustomerRelationshipsNoncompeteAgreementsAndPatentsMember" id="tech_TradeNamesCustomerRelationshipsNoncompeteAgreementsAndPatentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ChangzhouEminenceBiotechnologyMember" id="tech_ChangzhouEminenceBiotechnologyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="The2020EquityIncentivePlanMember" id="tech_The2020EquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PerformanceIncentiveProgramsMember" id="tech_PerformanceIncentiveProgramsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="USProfitSharingAndSavingsPlanMember" id="tech_USProfitSharingAndSavingsPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GBProfitSharingAndSavingsPlanMember" id="tech_GBProfitSharingAndSavingsPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingLossCarryforwardsMember" id="tech_OperatingLossCarryforwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TaxCreditCarryforwardsMember" id="tech_TaxCreditCarryforwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContingentConsiderationPolicyPolicyTextBlock" id="tech_ContingentConsiderationPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BuildingBuildingImprovementsAndLeaseholdImprovementsMember" id="tech_BuildingBuildingImprovementsAndLeaseholdImprovementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AcquisitionRelatedLiabilities" id="tech_AcquisitionRelatedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="VariableInterestEntityPrimaryBeneficiaryMaximumLossExposurePortionStemmingFromInitialInvestment" id="tech_VariableInterestEntityPrimaryBeneficiaryMaximumLossExposurePortionStemmingFromInitialInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="LesseeOperatingLeaseLeaseNotYetCommencedAnnualRentalImpact" id="tech_LesseeOperatingLeaseLeaseNotYetCommencedAnnualRentalImpact" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedForfeitureRate" id="tech_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedForfeitureRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationContingentConsiderationAdjustment" id="tech_EffectiveIncomeTaxRateReconciliationContingentConsiderationAdjustment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationOptionExercises" id="tech_EffectiveIncomeTaxRateReconciliationOptionExercises" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationGILTIAndFDIIPercent" id="tech_EffectiveIncomeTaxRateReconciliationGILTIAndFDIIPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredTaxAssetsLeaseLiabilities" id="tech_DeferredTaxAssetsLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="UnitedStatesAndCanadaMember" id="tech_UnitedStatesAndCanadaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfSharesAcquiredOnExerciseOfWarrants" id="tech_NumberOfSharesAcquiredOnExerciseOfWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ExchangeTradedInvestmentGradeBondFundsMember" id="tech_ExchangeTradedInvestmentGradeBondFundsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="TotalAssetsOfImpairedAssetGroup" id="tech_TotalAssetsOfImpairedAssetGroup" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ForwardContractPayment" id="tech_ForwardContractPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ExchangedTradedSecuritiesMember" id="tech_ExchangedTradedSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NamocellIncMember" id="tech_NamocellIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CentennialColoradoFacilityMember" id="tech_CentennialColoradoFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ImpactOfPartiallyOwnedConsolidatedSubsidiaries" id="tech_ImpactOfPartiallyOwnedConsolidatedSubsidiaries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="UndistributedEarningsOfForeignSubsidiariesNonPermanentlyReinvested" id="tech_UndistributedEarningsOfForeignSubsidiariesNonPermanentlyReinvested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="UndistributedEarningsOfForeignSubsidiariesPermanentlyAndNonPermanentlyReinvested" id="tech_UndistributedEarningsOfForeignSubsidiariesPermanentlyAndNonPermanentlyReinvested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteDeferredTaxesAndGoodwill" id="tech_BusinessCombinationProvisionalInformationInitialAccountingIncompleteDeferredTaxesAndGoodwill" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
</xsd:schema>
